CN Patent

CN106518849B — 喹唑啉类化合物及其制备方法和用途

Assigned to Shanghai Human Genome Research Center · Expires 2019-08-16 · 7y expired

What this patent protects

本发明公开了一种式(I)所示的喹唑啉类化合物或其可药用盐。本发明还公开了该类化合物的制备方法及其在制备治疗癌症的药物中的应用。本发明的化合物，能够抑制FAK激酶活性，能有效抑制癌细胞增殖，对多种癌症具有良好的治疗效果，尤其是对肝癌等具有显著的治疗效果，应用前景非常广阔。

USPTO Abstract

本发明公开了一种式(I)所示的喹唑啉类化合物或其可药用盐。本发明还公开了该类化合物的制备方法及其在制备治疗癌症的药物中的应用。本发明的化合物，能够抑制FAK激酶活性，能有效抑制癌细胞增殖，对多种癌症具有良好的治疗效果，尤其是对肝癌等具有显著的治疗效果，应用前景非常广阔。

Drugs covered by this patent

Patent Metadata

Patent number
CN106518849B
Jurisdiction
CN
Classification
—
Expires
2019-08-16
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Human Genome Research Center
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.